Clinical Trials Logo

Trichomonas Vaginitis clinical trials

View clinical trials related to Trichomonas Vaginitis.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06438575 Not yet recruiting - Bacterial Vaginosis Clinical Trials

Point of Care Diagnosis of Vaginal Infections

PAT
Start date: June 2024
Phase: N/A
Study type: Interventional

Vaginal infections are a common gynecologic issue and may cause significant symptoms and discomfort for individuals. Point of care tests are used to diagnose infections in the office, with an advantage of quick diagnosis and treatment. Examples of point of care tests are urine pregnancy, rapid strep and COVID-19 tests. This study will enroll persons with vaginal complaints and compare diagnosis and treatment based on usual care to diagnosis and treatment using a Food and Drug Administration-approved point of care test for the diagnosis of vaginitis. The study is being done to better understand diagnosis, treatment, and satisfaction using point of care tests compared to usual care. Participants will be randomized to one of two study arms: Arm 1: the healthcare provider will perform their usual evaluation and tests to make the diagnosis and provide treatment, as needed. Arm 2: the provider will be asked to use the results of the point-of-care test being used in the study to make the diagnosis and provide treatment, as needed. Regardless of arm, all diagnoses and treatment will be provided through the healthcare provider. All participants will be contacted 2 weeks later to answer a questionnaire related to diagnosis, treatment, current symptoms, and satisfaction with their visit. Medical records related to vaginal complaints, up to 30 days from enrollment, will be reviewed by the study team to obtain information on symptoms, tests performed, results, and treatments prescribed.

NCT ID: NCT06261840 Not yet recruiting - Clinical trials for Trichomonas Vaginitis

Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole

Start date: July 1, 2024
Phase: Phase 4
Study type: Interventional

This is a multi-centered, randomized, open-label, parallel, phase IV clinical trial comparing the effectiveness and cost-effectiveness of oral multi-dose metronidazole (MTZ) and oral single-dose secnidazole (SEC) for the treatment of Trichomonas vaginalis in both women and men.

NCT ID: NCT05383521 Not yet recruiting - Clinical trials for Trichomonas Vaginitis

Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis

Start date: December 1, 2025
Phase: N/A
Study type: Interventional

We compare two oral tinidazole regimens for refractory trichomonas vaginitis.

NCT ID: NCT03614286 Not yet recruiting - Clinical trials for Vaginitis Trichomonal

Trichomonas Vaginalis Genotyping in Upper Egypt

Start date: October 2018
Phase:
Study type: Observational

The worldwide incidence of trichomoniasis was estimated to be 276.4 million new cases per year in 2008 .In Egypt, the reported prevalence rate ranges from 5% to 79.16% we aim to study genetic variability of Trichomonas vaginalis using PCR